443 related articles for article (PubMed ID: 31959031)
1. Slug, a Cancer-Related Transcription Factor, is Involved in Vascular Smooth Muscle Cell Transdifferentiation Induced by Platelet-Derived Growth Factor-BB During Atherosclerosis.
Ledard N; Liboz A; Blondeau B; Babiak M; Moulin C; Vallin B; Guillas I; Mateo V; Jumeau C; Blirando K; Meilhac O; Limon I; Glorian M
J Am Heart Assoc; 2020 Jan; 9(2):e014276. PubMed ID: 31959031
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of S100A4 induces stabilization of atherosclerotic plaques: role of smooth muscle cells.
Sakic A; Chaabane C; Ambartsumian N; Klingelhöfer J; Lemeille S; Kwak BR; Grigorian M; Bochaton-Piallat ML
Cardiovasc Res; 2022 Jan; 118(1):141-155. PubMed ID: 33135065
[TBL] [Abstract][Full Text] [Related]
3. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.
Han JH; Park HS; Lee DH; Jo JH; Heo KS; Myung CS
Life Sci; 2021 Feb; 267():118978. PubMed ID: 33412209
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
6. Circ_0002984 Enhances Growth, Invasion, and Migration in PDGF-bb-Induced Vascular Smooth Muscle Cells Through miR-379-5p/FRS2 Axis.
Zheng X; Liu J; Gong X; Zhang X; Ma S
J Cardiovasc Pharmacol; 2021 Dec; 78(6):875-884. PubMed ID: 34882114
[TBL] [Abstract][Full Text] [Related]
7. Circ_CHFR Promotes Platelet-Derived Growth Factor-BB-Induced Proliferation, Invasion, and Migration in Vascular Smooth Muscle Cells via the miR-149-5p/NRP2 Axis.
Wang M; Li C; Cai T; Zhang A; Cao J; Xin H
J Cardiovasc Pharmacol; 2022 Jan; 79(1):e94-e102. PubMed ID: 33990513
[TBL] [Abstract][Full Text] [Related]
8. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
[TBL] [Abstract][Full Text] [Related]
9. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
10. PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns.
Thomas JA; Deaton RA; Hastings NE; Shang Y; Moehle CW; Eriksson U; Topouzis S; Wamhoff BR; Blackman BR; Owens GK
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H442-52. PubMed ID: 19028801
[TBL] [Abstract][Full Text] [Related]
11. Tryptanthrin Regulates Vascular Smooth Muscle Cell Phenotypic Switching in Atherosclerosis by AMP-Activated Protein Kinase/Acetyl-CoA Carboxylase Signaling Pathway.
Shi X; Zhang Y; Han J; Peng W; Fang Z; Qin Y; Xu X; Lin J; Xiao F; Zhao L; Lin Y
J Cardiovasc Pharmacol; 2021 May; 77(5):642-649. PubMed ID: 33951699
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-520c-3p targeting of RelA/p65 suppresses atherosclerotic plaque formation.
Wang J; Hu X; Hu X; Gao F; Li M; Cui Y; Wei X; Qin Y; Zhang C; Zhao Y; Gao Y
Int J Biochem Cell Biol; 2021 Feb; 131():105873. PubMed ID: 33166679
[TBL] [Abstract][Full Text] [Related]
13. The role of circadian clock gene BMAL1 in vascular proliferation.
Takaguri A; Sasano J; Akihiro O; Satoh K
Eur J Pharmacol; 2020 Apr; 872():172924. PubMed ID: 31958455
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor induces tissue factor expression in vascular smooth muscle cells via activation of Egr-1.
Kamimura M; Bea F; Akizawa T; Katus HA; Kreuzer J; Viedt C
Hypertension; 2004 Dec; 44(6):944-51. PubMed ID: 15492129
[TBL] [Abstract][Full Text] [Related]
15. TRIM65 promotes vascular smooth muscle cell phenotypic transformation by activating PI3K/Akt/mTOR signaling during atherogenesis.
Zhou ZX; Ma XF; Xiong WH; Ren Z; Jiang M; Deng NH; Zhou BB; Liu HT; Zhou K; Hu HJ; Tang HF; Zheng H; Jiang ZS
Atherosclerosis; 2024 Mar; 390():117430. PubMed ID: 38301602
[TBL] [Abstract][Full Text] [Related]
16. DLEU2 modulates proliferation, migration and invasion of platelet-derived growth factor-BB (PDGF-BB)-induced vascular smooth muscle cells (VSMCs) via miR-212-5p/YWHAZ axis.
Zhao Z; Zhang G; Yang J; Lu R; Hu H
Cell Cycle; 2022 Oct; 21(19):2013-2026. PubMed ID: 35775826
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.
Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765
[TBL] [Abstract][Full Text] [Related]
18. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of TRIM28 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration.
Liu H; Chen H; Deng X; Peng Y; Zeng Q; Song Z; He W; Zhang L; Xiao T; Gao G; Li B
Chem Biol Interact; 2019 Sep; 311():108772. PubMed ID: 31351049
[TBL] [Abstract][Full Text] [Related]
20. Sulfiredoxin-1 Inhibits PDGF-BB-Induced Vascular Smooth Muscle Cell Proliferation and Migration by Enhancing the Activation of Nrf2/ARE Signaling.
Jiang H; Zhao Y; Feng P; Liu Y
Int Heart J; 2022 Jan; 63(1):113-121. PubMed ID: 35034915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
